[1] Swedish rectal cancer trial. improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med,1997,336:980-987. [2] Ridgway PF,Darzi AW. The role of total mesorectal excision in the management of rectal cancer. Cancer Control,2003,10:205-211. [3] Stockholm rectal cancer study group. Short-term preoperative radiotherapy for adenocarcinoma of the rectum.An interim analysis of a randomized multicenter trial. Am J Clin Oncol,1987,10:369-375. [4] Stockholm rectal cancer study group. preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer,1990,66:49-55. [5] Kapiteijn E,Marijnen CA,Nagtegaal ID,et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med,2001,345:638-646. [6] Quirke P,Dixon MF,Durdey P,et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet,1986,328:996-999. [7] Swedish rectal cancer trial group. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal CancerTrial. N Engl J Med,1997,336:980-987. [8] Nagtegaal ID,Marijnen CA,Kranenbarg EK,et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol,2002,26:350-357. [9] Sebag-Montefiore D,Stephens RJ,Steele R,et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer(MRC CR07 and NCICCTG C016): a multicentre,randomised trial. Lancet,2009,373:811-820. [10] Quirke P,Steele R,Monson J,et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet,2009,373:821-828. [11] Purkayastha S,Tekkis PP,Athanasiou T,et al. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis,2007,9:402-411. [12] Sauer R,Becker H,Hohenberger W,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med,2004,351:1731-1740. [13] Yun HR,Chun HK,Lee WS,et al. Intra-operative measurement of surgical lengths of the rectum and the peritoneal reflection in Korean. J Korean Med Sci,2008,23:999-1004. [14] Stocchi L,Nelson H,Sargent DJ,et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol,2001,19:3895-3902. [15] Gunderson LL,Sargent DJ,Tepper JE,et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol,2004,22:1785-1796. [16] Fisher B,Wolmark N,Rockette H,et al. Postoperative adjuvantchemotherapy or radiation therapy for rectal cancer: results fromNSABP protocol R-01. J Natl Cancer Inst,1988,80:21. [17] Thomas PR,Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the gastrointestinal tumor study group experience. Radiother Oncol,1988,13:245-252. [18] de Gramont A,Figer A,Seymour M,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol,2000,18:2938-2947. [19] Collette L,Bosset JF,den Dulk M,et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European organisation for research and treatment of Cancer radiation oncology group. J Clin Oncol,2007,25:4379-4386 [20] Douillard JY,Cunningham D,Roth AD,et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet,2000,355:1041-1047. [21] Andre T,Boni C,Navarro M,et al. Improved overall survival with oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment in stage Ⅱ or Ⅲ colon cancer in the MOSAIC trial. J Clin Oncol,2009,27:3109-3116. [22] Cunningham D,Atkin W,Lenz HJ,et al. Colorectal Cancer. Lancet,2010,375:1030-1047. [23] Nissan A,Stojadinovic A,Shia J,et al. Predictors of recurrence in patients with T2 and early T3,N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol,2006,24:4078-4084. [24] Dresen RC,Peters EE,Rutten HJ,et al. Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol,2009,35:1071-1077. [25] Roh MS,Colangelo LH,O′Connell MJ,et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol,2009,27:5124-5130. [26] Lombardi R,Cuicchi D,Pinto C,et al. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment? Ann Surg Oncol,2009,17:838-845. [27] Weiser MR,Quah HM,Shia J,et al. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg,2009,249:236-242. [28] Stephens RJ,Thompson LC,Quirke P,et al. Impact of short-course preoperative radiotherapy for rectal cancer on patients′ quality of life: data from the medical research council CR07/national cancer institute of Canada clinical trials group C016 randomized clinical trial. J Clin Oncol,2010,28:4233-4239. [29] Peeters KC,van de Velde CJ,Leer JW,et al. Late side effectsof short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. J Clin Oncol,2005,23:6199-6206. [30] Haddock MG,Sloan JA,Bollinger JW,et al. Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase Ⅲ north central cancer treatment group clinical trial. J Clin Oncol,2007,25:1255-1259. [31] Bujko K,Nowacki MP,Nasierowska-Guttmejer A,et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg,2006,93:1215-1223.